Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Cheap Stocks To Buy Now? Hot Penny Stocks To Watch In October
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Form 8-K Chardan NexTech Acquisit For: Sep 29
-
Scribe Therapeutics to Participate in Upcoming Investor Conferences
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Start-up Etioca eyes Nasdaq listing next year as it unveils electric taxi
-
Forge Biologics to Present and Participate at Upcoming Investor Conferences
-
ReCode Therapeutics to Participate in Upcoming October Investor Conferences
-
Solid Biosciences to Participate at Upcoming Investor Conferences
-
Best Penny Stocks To Buy Now? 3 To Watch As Stock Market Crash Continues
-
Best Penny Stocks To Buy Now? 3 To Watch As Stock Market Crash Continues
-
Tenaya Therapeutics to Participate in Upcoming October Investor and Industry Conferences
-
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Krystal Biotech to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Adverum Biotechnologies to Participate in the Chardan 6th Annual Genetic Medicines Conference
-
Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
IMUNON to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
IMUNON to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
TransCode Therapeutics to Participate at the Chardan 6th Annual Genetic Medicines Conference
-
TransCode Therapeutics to Participate at the Chardan 6th Annual Genetic Medicines Conference
-
Rocket Pharmaceuticals to Present at Chardan 6th Annual Genetic Medicines Conference
-
Dragonfly Energy Strengthens Partnership with Keystone RVs
-
Dragonfly Energy Strengthens Partnership with Keystone RVs
-
Dyne Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Dyne Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
REGENXBIO Announces Presentation at Chardan's 6th Annual Genetic Medicines Conference
-
Voyager Therapeutics to Participate in Upcoming Investor Conferences
-
Silence Therapeutics to Participate in Fireside Chat at Chardan Genetic Medicines Conference
-
Cabaletta Bio to Present at the Chardan 6th Annual Genetic Medicines Conference
-
Cabaletta Bio to Present at the Chardan 6th Annual Genetic Medicines Conference
-
Intellia Therapeutics to Present at October Healthcare Investor Conferences
-
Century Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Oncorus to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Passage Bio to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Century Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Oncorus to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Passage Bio to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Omega Therapeutics to Participate in Two Upcoming Investor Conferences
-
Sensorion to Participate in Various Upcoming Investor Conferences
-
Form 4 Presto Automation Inc. For: Sep 21 Filed by: Chardan International Investments, LLC
-
UPDATE: Chardan Capital Markets Starts Omega Therapeutics (OMGA) at Buy
-
UPDATE: Chardan Capital Markets Starts Senti Biosciences, Inc. (SNTI) at Buy, PT $12
-
NeuBase to Participate at Chardan’s 6th Annual Genetic Medicines Conference
-
Arbor Biotechnologies to Participate in Upcoming Healthcare Investor Conferences
-
NextRNA Therapeutics to Participate in Upcoming BioPharm America and Chardan’s 6th Annual Genetic Medicines Conference
-
Arbutus to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Arbutus to Present at Chardan’s 6th Annual Genetic Medicines Conference
